Neuroplast Completes Phase II Clinical Trial Inclusion for Traumatic Spinal Cord Injury
![Neuroplast logo](https://nationalstemcelltherapy.com/wp-content/uploads/2023/09/Neuroplast_Logo-1024x289.jpg)
Neuroplast, a Dutch clinical-stage biotech company, has successfully concluded the patient inclusion for its Phase II clinical trial, focusing on Traumatic Spinal Cord Injury (TSCI). Here are the key details: Thought-Provoking Questions/Insights: Original Press Release